AtheroGenics   Report issue

For profit Phase 3
Founded: Alpharetta GA United States (1993)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2003
NCT00066898
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

AtheroGenics, Inc